Prurigo Nodularis Latest Advances
Find the Latest Research About Prurigo Nodularis
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 771 publications
The patient journey in prurigo nodularis: what lies ahead.
Journal: Expert opinion on biological therapy
Published: April 01, 2026
Correction: Dupilumab Reduces Pruritus in Clinically Distinct Dermatologic Diseases: Data from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria.
Journal: Dermatology and therapy
Published: March 19, 2026
Dupilumab subgroup responder analysis: a post hoc analysis from LIBERTY PRIME and PRIME2 in prurigo nodularis.
Journal: The Journal of dermatological treatment
Published: March 11, 2026
Targeting the neuroimmune axis in prurigo nodularis: a critical appraisal of the nemolizumab trials.
Targeting the neuroimmune axis in prurigo nodularis: a critical appraisal of the nemolizumab trials.
Journal: Expert opinion on biological therapy
Published: February 19, 2026
Letter: The Relationship Between Prurigo Nodularis and Chronic Infectious Disease: A Systematic Review and Meta-Analysis.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: February 17, 2026
Prurigo Nodularis paTient Reported burdEn of sicKness in Europe (PN TREK Europe): a cross-sectional survey of patient-reported burden of disease in patients with PN from four countries in Europe.
Journal: The Journal of dermatological treatment
Published: February 17, 2026
Therapeutic Efficacy of Oral Tofacitinib in Pediatric Prurigo Nodularis: A Case Series With a Review of Literature.
Journal: Journal of cutaneous medicine and surgery
Published: February 08, 2026
Prurigo Nodularis and the Pain Cascade: Understanding the Pathogenesis and Approach to Management.
Journal: The Journal of clinical and aesthetic dermatology
Published: February 06, 2026
Letter: Post-Marketing Efficacy of Nemolizumab for Prurigo Nodularis: A Single-Center Study with a Small Sample Size.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: February 06, 2026
Prurigo nodularis enters the biologic era: what has changed and what vixarelimab still must prove.
Journal: The Journal of dermatological treatment
Published: February 02, 2026
The epidemiology of prurigo nodularis in Belgium.
Journal: European journal of dermatology : EJD
Published: January 29, 2026
Impact of Chronic Nodular Prurigo on Quality of Life: A Systematic Review of the Literature.
Journal: Dermatology and therapy
Published: January 22, 2026
Last Updated: 04/28/2026